Loading…
A study of autologous melanocyte transfer in treatment of stable vitiligo
Background: Replenishing melanocytes selectively in vitiliginous macules by autologous melanocytes is a promising treatment. With expertise in culturing melanocytes, it has now become possible to treat larger recipient areas with smaller skin samples. Aim: To study the extent of repigmentation after...
Saved in:
Published in: | Indian journal of dermatology, venereology, and leprology venereology, and leprology, 2005-11, Vol.71 (6), p.393-397 |
---|---|
Main Author: | |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Background: Replenishing melanocytes selectively in vitiliginous
macules by autologous melanocytes is a promising treatment. With
expertise in culturing melanocytes, it has now become possible to treat
larger recipient areas with smaller skin samples. Aim: To study the
extent of repigmentation after autologous melanocyte transplantation in
patients with stable vitiligo. Methods: The melanocytes were harvested
as an autologous melanocyte rich cell suspension from a donor split
thickness graft. Melanocyte culture was performed in selected cases
where the melanocyte cell count was insufficient to meet the
requirement of the recipient area. These cells were then transplanted
to the recipient area that had been superficially dermabraded.
Results: An excellent response was seen in 52.17% cases with the
autologous melanocyte rich cell suspension (AMRCS) technique and in 50%
with the melanocyte culture (MC) technique. Conclusion: Autologous
melanocyte transplantation can be an effective form of surgical
treatment in stable but recalcitrant lesions of vitiligo. |
---|---|
ISSN: | 0378-6323 1998-3611 |
DOI: | 10.4103/0378-6323.18942 |